Coronavirus vaccine to be ready in early 2021 - Sage expert | The Business Standard
Skip to main content
  • Latest
  • Economy
    • Banking
    • Stocks
    • Industry
    • Analysis
    • Bazaar
    • RMG
    • Corporates
    • Aviation
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • Subscribe
    • Epaper
    • GOVT. Ad
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
The Business Standard

Friday
July 11, 2025

Sign In
Subscribe
  • Latest
  • Economy
    • Banking
    • Stocks
    • Industry
    • Analysis
    • Bazaar
    • RMG
    • Corporates
    • Aviation
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • Subscribe
    • Epaper
    • GOVT. Ad
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
FRIDAY, JULY 11, 2025
Coronavirus vaccine to be ready in early 2021 - Sage expert

Coronavirus chronicle

TBS Report
19 October, 2020, 08:45 am
Last modified: 19 October, 2020, 09:01 am

Related News

  • WHO SAGE to review AstraZeneca vaccine against new Covid variants
  • The ethics of vaccine trial on humans
  • Another potential Covid-19 vaccine to enter clinical trial today
  • Australia gives free childcare as coronavirus case curve flattens
  • FDA warns against using Chloroquine intended for fish as treatment for COVID-19

Coronavirus vaccine to be ready in early 2021 - Sage expert

The expert said the UK faces a 'very, very difficult' period over the next three to six months

TBS Report
19 October, 2020, 08:45 am
Last modified: 19 October, 2020, 09:01 am
Photo: Reuters 
Photo: Reuters 

Jeremy Farrar, a member of the Scientific Advisory Group for Emergencies (Sage) predicts a Covid vaccine will be ready within the first three months of 2021.

The expert said the UK faces a 'very, very difficult' period over the next three to six months, reports Daily Mail.

But the Wellcome Trust director said there is 'light at the end of the tunnel', as he believes a Covid-19 vaccine and effective treatment will be ready in the first quarter of 2021.

The Business Standard Google News Keep updated, follow The Business Standard's Google news channel

It comes as England's Deputy Chief Medical Officer Jonathan Van-Tam has said the vaccine being prepared at Oxford University could be ready by December.

Meanwhile, drug giant Pfizer has released a video showing that production of their vaccine is well under way at the manufacturing plant in Belgium. 

Prof Farrar told Sky News' Sophy Ridge on Sunday a circuit-breaker national lockdown is now needed, claiming there could currently be 50,000 coronavirus cases per day across the UK.

He said: 'The ONS (Office for National Statistics) survey, which is the best data in the country at the moment, shows that 27,000 people are getting this infection every day. But that was until the 10th of October.

'Today it will be over 50,000, just as the CMO (England's chief medical officer) Chris Whitty and (the Government's chief scientific adviser) Sir Patrick Vallance suggested some three weeks ago.

'It would be at 50,000 new cases across the country every single day, and that's almost exactly where we are.'

Asked about Christmas, Prof Farrar said he does not believe a vaccine will be ready in time for the festive period.

He added: 'Christmas will be tough this year. I don't think it's going to be the usual celebration it is and all families coming together, I'm afraid.

'I think we have to be honest and realistic and say that we are in for three to six months of a very, very difficult period.

'The temperatures drop, we are all indoors more often, we have the other infections that come this time of year.

'It's much better for us to be upfront and honest now, and say we are in for a really difficult time, but there is light at the end of the tunnel.'

Prof Farrar said a short national lockdown known as a circuit-breaker is needed to reduce transmission rates, as previously recommended by Sage last month.

He said the 'best time' to have introduced the temporary lockdown would have been around September 20, but added 'it was never too late'.

He said: 'The second best time to do this is now, and the worst time to do this is at the end of November when things would have really got considerably worse.

'So it's never too late, it's better to do it now than in a month's time.'

In regard to a potential vaccine and effective treatments, Prof Farrar said he believes they are 'three to six months away'.

Meanwhile, new footage has emerged which shows the vaccine that could end the Covid misery engulfing the planet.

Drug giant Pfizer has already manufactured 'several hundred thousand doses' of the jab at its plant in Puurs, Belgium, The Mail on Sunday can reveal.

They are being stockpiled ready to be rolled out worldwide if clinical trials are a success, and regulators deem it safe and effective.

The US giant hopes to make 100 million doses available this year, of which 40 million are destined for the UK – a figure that will be dwarfed by the 1.3 billion jabs the company aims to manufacture in 2021. 

Every patient who receives the vaccine will need two doses.

In an interview with The Mail on Sunday today, Pfizer UK boss Ben Osborn says: 'It was great to see the first vial coming off the manufacturing line. 

'It just brought a tremendous smile to my face to see all of this work actually result in a product.' 

Pfizer, which is working with Germany's BioNTech, is currently running a trial on 44,000 people, and last week said it plans to apply for emergency US approval of its vaccine in November.  

That puts Pfizer in pole position in the race to launch a Covid vaccine.

Separately, Osborn said Pfizer's laboratory in Sandwich, Kent, has unearthed drugs that could provide a potential cure for Covid-19. 

It comes as it was today reported that the NHS is preparing to introduce a coronavirus vaccine soon after Christmas.

The UK's deputy chief medical officer, Jonathan Van-Tam, reportedly told MPs last week that stage three trials of the vaccine created at Oxford University, which is being produced by Astra Zeneca, could be rolled-out in December, reports the Sunday Times.  

According to the paper, he said: 'We aren't light years away from it. It isn't a totally unrealistic suggestion that we could deploy a vaccine soon after Christmas. 

'That would have a significant impact on hospital admissions and deaths.' 

Thousands of NHS staff are to undergo training to administer a vaccine before the end of the year, the paper adds.

Meanwhile, Boris Johnson is under growing pressure from furious Tory grandees to set out a 'clear end date' for local lockdowns.

Senior Conservative Party figures have warned the Prime Minister he must announce a 'strategy for returning life to normal' as they said an indefinite cycle of localised shutdowns is not acceptable and would wreck the economy. 

Top News

Corona virus vaccine / SAGE

Comments

While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.

Top Stories

  • Bangladesh's delegation, led by Commerce Adviser Sk Bashir Uddin, began high-level negotiations with USTR Ambassador Jamieson Greer at 9pm Bangladesh time on Thursday (10 July). Photo: Collected from the Facebook handle of Golam Mortoza, Press Minister at the Bangladesh Embassy in the US
    No need to worry as US tariff talks ongoing: Fouzul tells biz leaders
  • Commerce Adviser Sk Bashir Uddin met USTR Ambassador Jamieson Greer at the USTR office in Washington, DC on 10 July 2025. Photo: CA Press Wing
    35% tariff: Commerce adviser meets US trade representative in Washington
  • Economist Abul Barkat; Photo: Courtesy
    Economist Abul Barkat arrested in graft case

MOST VIEWED

  • Graphics: TBS
    BB raises startup fund limit, drops upper age barrier
  • Workers pack undergarments at the packing section of a garment factory in Ashulia, on the outskirts of Dhaka, Bangladesh, April 19, 2025. Photo: REUTERS/Fatima Tuj Johora
    After US tariffs, jobs hang by a thread in Bangladesh's garments sector
  • Photo: Mohammad Minhaj Uddin/TBS
    SSC, equivalent results: Pass rate drops to 68.45%, GPA-5 also declines
  • File photo of containers at Chattogram port/TBS
    US buyers push Bangladeshi exporters to share extra tariff costs
  • Govt vehicle purchase, foreign trip, new building construction banned: Finance ministry
    Govt vehicle purchase, foreign trip, new building construction banned: Finance ministry
  • Students sit for SSC exam at Motijheel Girls' High School on 10 April 2025. Photo: Mehedi Hasan/TBS
    SSC exam results out: Here's how you can check online and via SMS

Related News

  • WHO SAGE to review AstraZeneca vaccine against new Covid variants
  • The ethics of vaccine trial on humans
  • Another potential Covid-19 vaccine to enter clinical trial today
  • Australia gives free childcare as coronavirus case curve flattens
  • FDA warns against using Chloroquine intended for fish as treatment for COVID-19

Features

Photo: Collected/BBC

What Hitler’s tariff policy misfire can teach the modern world

11h | The Big Picture
Illustration: TBS

Behind closed doors: Why women in Bangladesh stay in abusive marriages

14h | Panorama
Purbachl’s 144-acre Sal forest is an essential part of the area’s biodiversity. Within it, 128 species of plants and 74 species of animals — many of them endangered — have been identified. Photo: Syed Zakir Hossain/TBS

A forest saved: Inside the restoration of Purbachal's last Sal grove

14h | Panorama
Photo: Rajib Dhar/TBS

11 July 2024: Riot vehicles, water cannons hit the streets as police crack down on protesters

7h | Panorama

More Videos from TBS

'Hypocrisy' will not continue, Iran tells IAEA

'Hypocrisy' will not continue, Iran tells IAEA

10h | TBS World
OpenAI to release web browser in challenge to Google Chrome

OpenAI to release web browser in challenge to Google Chrome

10h | TBS World
Will the title 'Honorable and Excellency' be abolished?

Will the title 'Honorable and Excellency' be abolished?

11h | TBS Today
July Declaration must be constitutionally recognized: Akhtar Hossain

July Declaration must be constitutionally recognized: Akhtar Hossain

10h | TBS Today
EMAIL US
contact@tbsnews.net
FOLLOW US
WHATSAPP
+880 1847416158
The Business Standard
  • About Us
  • Contact us
  • Sitemap
  • Advertisement
  • Privacy Policy
  • Comment Policy
Copyright © 2025
The Business Standard All rights reserved
Technical Partner: RSI Lab

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - oped.tbs@gmail.com

For advertisement- sales@tbsnews.net